期刊文献+

口服避孕药与天然孕激素治疗青春期功血的临床分析 被引量:5

Analysis of Oral Contraceptives and Natural Progesterone in the Treatment of Adolescent Function
下载PDF
导出
摘要 目的对应用避孕药与孕激素联合对患有青春期功能性子宫出血疾病的患者实施治疗的临床效果进行研究。方法选择在我院就诊的患有青春期功能性子宫出血疾病的患者82例,随机分为对照组和治疗组,平均每组41例。采用孕激素对对照组患者实施治疗;采用避孕药与孕激素联合对治疗组患者实施治疗。结果治疗组患者青春期功能性子宫出血疾病药物治疗效果明显优于对照组;子宫出血停止时间和药物治疗计划实施总时间明显短于对照组;药物原因导致的不良反应明显少于对照组。结论应用避孕药与孕激素联合对患有青春期功能性子宫出血疾病的患者实施治疗的临床效果非常明显。 Objective To study the clinical effect of the application of the pill and the combination of progesterone and progesterone in the treatment of patients with dysfunctional uterine bleeding.. Methods 82 patients with dysfunctional uterine bleeding who were treated in our hospital were randomly divided into control group and treatment group, with average of 41 cases in each group. The treatment of the patients in the control group was treated by using progesterone, and the treatment group was treated by the combination of pill and progesterone. Results In the treatment group of adolescent patients with functional uterine bleeding disease drug treatment is superior to the control group; uterine bleeding time and drug treatment program to stop the implementation of total time was significantly shorter than that of the control group; drug causes of adverse reaction was significantly less than that of the control group. Conclusions The clinical effect of the application of the pill and the combination of progesterone and progesterone in the treatment of patients with dysfunctional uterine bleeding is obvious.
作者 殷慧荣
出处 《中国医药指南》 2016年第13期10-10,13,共2页 Guide of China Medicine
关键词 避孕药 孕激素 青春期功能性子宫出血 治疗 Contraceptives Progesterone Adolescent dysfunctional uterine bleeding Treatment
  • 相关文献

参考文献6

二级参考文献15

  • 1蒋国庆,廉玉茹.释放左炔诺孕酮的宫内节育器治疗子宫腺肌病[J].中国妇产科临床杂志,2005,6(3):177-178. 被引量:51
  • 2徐定英,叶玲玲.米非司酮治疗围绝经期功血的临床观察[J].浙江临床医学,2005,7(8):858-858. 被引量:8
  • 3Higham JM, O'Brien PMS, Shaw RW. Assessment of menstrual blood loss using a pictorial chart[J]. Br J Obstetr Gynecol, 1990,97(8):734-739. 被引量:1
  • 4Gardner FJE, Konje JC, Abras KR, et al. Endometrial protection from tamoxifen- stimulated changes by a levonorgestrel-re leasing intrauterine system a randomized controlled trial[J].The Lancet, 2000, 356 (9243): 1711-1717. 被引量:1
  • 5Vereide AB, Ames M, Straume B, et al. Nuclear morphemetric changes and ther apy monitoring in patiens with endome trial hyperplasica: a study comparing ef fects of intrauterine levonorgestrel and systemic medroxyprogesterone[J].Gynecol Oncol, 2003, 91(3): 526-533. 被引量:1
  • 6Chi l-C, Farr G. The non-contraceptive effects of the levonorgestrel- releasing in trauterine device[J]. Contraeept, 1994, 10 (4): 271-285. 被引量:1
  • 7Xie X, Lu WG,Ye DF,et al. The value of curettage in diagnosis of endometrial hyperplasia [J]. Gynecol Oncol, 2002, 84 ( 1 ) :135-139. 被引量:1
  • 8Msowter MD. New surgical treatments for menorrhagia[J]. Lancet,2003,361 : 1456-1458. 被引量:1
  • 9Downest E, Odenovan P. Macrowave endometfial ablation in the management of menorrhagia:current status[J]. Curr Opin Obstet Gynecol,2000,12 ( 4 ) : 293-296. 被引量:1
  • 10乐杰.妇产科学[M].5版.北京:人民卫生出版社,2003:34-35. 被引量:15

共引文献349

同被引文献27

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部